Abhishek Jha

Hi, I’m AJ—scientist turned founder, CEO of Elucidata, and someone who’s spent the last decade thinking about what makes biomedical R&D actually work—and what quietly holds it back.

🎉 You're subscribed!
Check your inbox for our welcome email.

Don’t see it? Look in Promotions or Spam.
Mark it as important so future updates land in your inbox!

Oops! Something went wrong while submitting the form.

This newsletter is where I share thoughts that don’t always fit neatly into LinkedIn posts—on broken data pipelines, misunderstood AI claims, and what it really takes to build trustworthy systems in healthcare and biotech. Sometimes it’s sharp, sometimes it’s personal—but always rooted in real-world experience.

If you care about where the future of biomedical discovery is headed (and want to skip the hype), you’ll feel right at home here.

No noise

Always honest

Just one email a month

Some of my older newsletters

Discovery Is Dead, Long Live Discovery—in the Age of Empty Budgets

In the next 3-5 years, Spatial Biology will become a mainstream tool in the repertoire of R&D teams.

Unknown Data Quality from 'Research Use Only' Collaborations is a Business Risk for Dx Companies!

A conversation with Prof. Kim, an oncologist and CEO of IMBDx—a publicly traded diagnostics company based in South Korea—left me reflecting on a harsh truth that many in the field grapple with.

The onslaught of LLMs is overwhelming but there is silver lining here!

Clearly there is a broad range of options and we are all better off for that but the trend is unmistakable: the models will not be the most differentiated asset. Instead, the focus will shift to other aspects.

When Past Dreams Meet Present Tools- A New Era for Foundation Models

It is a noisy world out there. 10s of papers on foundation model every week, 100s of conferences, your news feed, AI companies doing massive funding rounds.

Reflecting, Celebrating, and Looking Ahead: Lessons from Our Offsite.

To everyone at Elucidata: take a moment to celebrate. Celebrate the fact that we are growing sustainably and our growth is accelerating! Embrace learning, adapting to new realities and emerging stronger.

From Maps to Medicine

In the next 3-5 years, Spatial Biology will become a mainstream tool in the repertoire of R&D teams.